Evaluated by: David B. Kaminsky, M.D., FIAC, May 21, 2017
Original release date: November 17, 2017
Access to this course expires on: May 19, 2020
Faculty: Donna E. Hansel, M.D., Ph.D.
- Identify key urothelial, squamous and glandular in situ lesions of the urinary tract
- Distinguish malignant precursor lesions from benign mimickers
- Understand the limitations of immunohistochemistry in the in situ setting
To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.
$75.00 - $100.00